TD Waterhouse Canada’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
36,694
+34,892
+1,936% +$862K ﹤0.01% 625
2026
Q1
$37.1K Buy
1,802
+270
+18% +$4.58K ﹤0.01% 1434
2025
Q4
$20.5K Sell
1,532
-4,062
-73% -$50.3K ﹤0.01% 1388
2025
Q3
$69.1K Sell
5,594
-63
-1% -$588 ﹤0.01% 1117
2025
Q2
$37.7K Buy
5,657
+661
+13% +$4.35K ﹤0.01% 1187
2025
Q1
$27.5K Buy
4,996
+661
+15% +$4.73K ﹤0.01% 1205
2024
Q4
$30.1K Hold
4,335
– – ﹤0.01% 1192
2024
Q3
$24.3K Sell
4,335
-163
-4% -$1.13K ﹤0.01% 1198
2024
Q2
$32K Sell
4,498
-39
-0.9% -$341 ﹤0.01% 1127
2024
Q1
$59.9K Buy
4,537
+3,880
+591% +$22.1K ﹤0.01% 1001
2023
Q4
$2.92K Sell
657
-110
-14% -$331 ﹤0.01% 1451
2023
Q3
$2.7K Sell
767
-1,030
-57% -$4.23K ﹤0.01% 1461
2023
Q2
$7.92K Buy
1,797
+1,062
+144% +$3.66K ﹤0.01% 1297
2023
Q1
$2.54K Sell
735
-293
-29% -$974 ﹤0.01% 1487
2022
Q4
$3.06K Buy
1,028
+373
+57% +$1.04K ﹤0.01% 1432
2022
Q3
$2.44K Buy
655
+145
+28% +$1.39K ﹤0.01% 1478
2022
Q2
$5.2K Sell
510
-160
-24% -$2.02K ﹤0.01% 1386
2022
Q1
$12.4K Sell
670
-223
-25% -$3.87K ﹤0.01% 1274
2021
Q4
$21.8K Buy
+893
New +$28.5K ﹤0.01% 1185

Other funds holding DFTX

TD Waterhouse Canada's DFTX Position: Q2 2026 in Review

TD Waterhouse Canada increased its Definium Therapeutics (DFTX) stake by 1,936% in Q2 2026, buying an estimated $862K and bringing the position to 36,694 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #625.

TD Waterhouse Canada first reported a position in DFTX in Q4 2021 and has held it in 19 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • TD Waterhouse Canada held 36,694 shares of Definium Therapeutics worth $1.59M as of Q2 2026.
  • TD Waterhouse Canada bought 34,892 Definium Therapeutics shares in Q2 2026, an estimated $862K.
  • Definium Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #625 holding.
  • TD Waterhouse Canada first reported a position in Definium Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.